Archive
Ask the expert webinar: Questions about ADHD
News published on February 12, 2025
The public is invited to a webinar to ask questions of leading specialists about the latest research into attention deficit hyperactivity disorder (ADHD), hosted by the National Institute for Health and Care Research (NIHR) Research Delivery Network.
Trial for blood tests to diagnose dementia accepts first participants at Warneford Hospital
News published on January 29, 2025
A country-wide trial aiming to revolutionise how dementia is diagnosed using blood tests is now underway, in a bid to improve the UK’s diagnosis rate.
New study for Treatment-Resistant Depression launches at Oxford Health Clinical Research Facility
News published on January 28, 2025
Recently, the NIHR Oxford Health Clinical Research Facility (OH CRF) has begun researching a new potential drug treatment for Treatment-Resistant Depression.
Oxford Health Biomedical Research Centre January Newsletter now available
News published on January 24, 2025
The January issue of the OH BRC Newsletter is available to read on the OH BRC website.
Oxford clinical lecturer awarded the Sir Jules Thorn Award for internationally outstanding research
News published on January 17, 2025
Dr Maxime Taquet has been awarded the 2024 Sir Jules Thorn Award for Biomedical Research. The Award recognises the outstanding quality of his cutting-edge research.
Oxford Health NHS Foundation Trust Research & Development 2024 Highlights
News published on January 15, 2025
As the new year begins, we take the opportunity to reflect on the many successes, changes and developments during 2024 across the research infrastructures at Oxford Health NHS Foundation Trust (OHFT).
Oxford Health Director of Research and Development discusses READ-OUT with BBC South
News published on December 24, 2024
Oxford Health NHS Foundation Trust Director of Research and Development, Professor Vanessa Raymont featured on the BBC.
Oxford and Southampton study identifies the most effective treatments for ADHD in adults
News published on December 18, 2024
Oxford and Southampton researchers have found that atomoxetine and a class of drug known as stimulants are the most effective treatments in the management of attention deficit hyperactivity disorder (ADHD) symptoms in adults.
Oxford Health Biomedical Research Centre (OH BRC) December Newsletter now available
News published on December 16, 2024
The December issue of the OH BRC Newsletter is available to read on the OH BRC website.
Do you or a loved one have Down syndrome? The ABATE study Part 2 is recruiting now!
News published on December 10, 2024
The ABATE study Part 2 is testing an investigational vaccine to slow the progression of Alzheimer’s disease in people with Down Syndrome, as currently there is no cure for Alzheimer’s disease.